Dupilumab for Trichothiodystrophy-Case Report and Review of the Literature
Dupilumab for Trichothiodystrophy-Case Report and Review of the Literature

Dupilumab for Trichothiodystrophy-Case Report and Review of the Literature

Clin Case Rep. 2026 Apr 3;14(4):e72473. doi: 10.1002/ccr3.72473. eCollection 2026 Apr.

ABSTRACT

Trichothiodystrophy (TTD) arises from pathogenic changes in several genes, most of which participate in DNA repair or transcriptional and translational processes. Atopic dermatitis may accompany TTD in a minority of cases. Dupilumab can offer a safe and effective treatment option for severe atopic dermatitis in this population.

PMID:41948753 | PMC:PMC13052132 | DOI:10.1002/ccr3.72473